Effect of Sex on Clinical Outcome and Imaging after Endovascular Treatment of Large-Vessel Ischemic Stroke.

Effect of Sex on Clinical Outcome and Imaging after Endovascular Treatment of Large-Vessel Ischemic Stroke.
复制标题

性别对大血管缺血性中风血管内治疗后的临床结果和成像的影响。

DOI:
10.1016/j.jstrokecerebrovasdis.2020.105468
复制
发表时间:
2021-03
期刊:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
影响因子:
--
通讯作者:
Lansberg MG
Lansberg MG
中科院分区:
其他
文献类型:
--
作者:
Demeestere J;Christensen S;Mlynash M;Federau C;Albers GW;Lemmens R;Lansberg MG

文献摘要

参考文献

被引文献

相似文献

It is unclear if sex differences explain some of the variability in the outcomes of stroke patients who undergo endovascular treatment (EVT). In this study we assess the effect of sex on radiological and functional outcomes in EVT-treated acute stroke patients and determine if differences in baseline perfusion status between men and women might account for differences in outcomes. We included patients from the CRISP (Computed tomographic perfusion to Predict Response to Recanalization in ischemic stroke) study, a prospective cohort study of acute stroke patients who underwent EVT up to 18 hours after last seen well. We designed ordinal regression and univariable and multivariable regression models to examine the association between sex and infarct growth, final infarct volume and 90-day mRS score. We included 198 patients. At baseline, women had smaller perfusion lesions, more often had a target mismatch perfusion profile, and had better collateral perfusion. Women experienced less ischemic core growth (median 15 mL vs. 29 mL, p < 0.01) and had smaller final infarct volumes (median 26 mL vs. 50 mL, p < 0.01). Female sex was associated with a favorable shift on the modified Rankin Scale (adjusted cOR 1.79 [1.04 – 3.08; p = 0.04]) and lower odds of severe disability or death (adjusted OR 0.29 [0.10 – 0.81]; p = 0.02). The results suggest that women have better collaterals and, therefore, more often exhibit a favorable imaging profile on baseline imaging, experience less lesion growth, and have better clinical outcomes following endovascular therapy.
DOI: 10.1161/strokeaha.119.028205
发表时间: 2020-02-01
期刊: STROKE
影响因子: 8.3
作者:
Dula, Adrienne N.;Mlynash, Michael;Warach, Steven J.
通讯作者: Warach, Steven J.
DOI: 10.1161/strokeaha.118.023867
发表时间: 2019-09-01
期刊: STROKE
影响因子: 8.3
作者:
Sheth, Sunil A.;Lee, Songmi;Saver, Jeffrey L.
通讯作者: Saver, Jeffrey L.
DOI: 10.1111/ene.14181
发表时间: 2020-05-01
影响因子: 5.1
作者:
Guenego, A.;Fahed, R.;Heit, J. J.
通讯作者: Heit, J. J.
DOI: 10.1161/strokeaha.113.004072
发表时间: 2014-03
期刊: Stroke
影响因子: 8.3
作者:
Liebeskind DS;Tomsick TA;Foster LD;Yeatts SD;Carrozzella J;Demchuk AM;Jovin TG;Khatri P;von Kummer R;Sugg RM;Zaidat OO;Hussain SI;Goyal M;Menon BK;Al Ali F;Yan B;Palesch YY;Broderick JP;IMS III Investigators
通讯作者: IMS III Investigators
DOI: 10.1161/01.str.0000259711.13490.23
发表时间: 2007-04-01
期刊: STROKE
影响因子: 8.3
作者:
Arnold, Marcel;Kappeler, Liliane;Mattle, Heinrich P.
通讯作者: Mattle, Heinrich P.